Johns Hopkins ABX Guide
Cefprozil
INDICATIONS
FDA
FDA
- Upper respiratory tract infections (acute exacerbation of chronic bronchitis [AECB], otitis media, pharyngitis, acute sinusitis, tonsillitis)
- Secondary bacterial infection of acute bronchitis and AECB caused by S. pneumoniae, H. influenzae and M. catarrhalis.
- Uncomplicated skin and skin structure infections caused by MSSA and S. pyogenes.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 1, 2026
Citation
Soto, Caitlin, and Edina Avdic. "Cefprozil." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540099/all/Cefprozil.
Soto C, Avdic E. Cefprozil. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540099/all/Cefprozil. Accessed August 10, 2026.
Soto, C., & Avdic, E. (2026). Cefprozil. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540099/all/Cefprozil
Soto C, Avdic E. Cefprozil [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 August 10]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540099/all/Cefprozil.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefprozil
ID - 540099
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Avdic,Edina,Pharm.D.
Y1 - 2026/08/01/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540099/all/Cefprozil
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
